Hepatitis C News

• Hepatitis C Drugs Work Synergistically With Remdesivir Combining Gilead Sciences' antiviral drug remdesivir with oral drugs used to treat hepatitis C virus might be more effective than remdesivir alone, laboratory experiments suggest.
  Reuters Health Information, April 30, 2021
• Ravidasvir-Sofosbuvir Combo Promising in Hep C Infection A combination of ravidasvir and sofosbuvir appears to be an effective treatment for chronic hepatitis C virus infection across a diverse pool of patients who took part in a trial underway in Malaysia and Thailand.
  Reuters Health Information, April 28, 2021
• The IgA tTG for Celiac Disease: Not as Sensitive as We Thought? An analysis suggests caution in the interpretation of a negative IgA tTG to rule out celiac disease in clinical practice.
  Medscape Medical News, April 12, 2021
• ART Likely Less Effective in Women With HIV Versus Other Chronic Viral Illnesses HIV-infected women who underwent assisted reproductive technology (ART) had a lower live birth rate than those with chronic hepatitis B or hepatitis C virus in a cohort study.
  Reuters Health Information, March 31, 2021
• CROI 2021 'Minimal Monitoring' Approach to HCV Treatment May Simplify Care 'The COVID-19 pandemic has highlighted the urgent need for simple and safe models of HCV [care] delivery.'
  Medscape Medical News, March 15, 2021
• Remdesivir Is Big Win for Gilead -- Boosted by Taxpayers Its emergency-use approval by the FDA immediately drew a storm of criticism. The World Health Organization recommended against its use. Politicians railed at its $3,120 price tag.
  Kaiser Health News, January 28, 2021
• US Supreme Court Rebuffs Merck Appeal in Hepatitis C Patent Fight With Gilead The US Supreme Court on Tuesday rejected Merck's bid to revive a $2.54 billion jury verdict it won against rival drugmaker Gilead Sciences for infringing a patent in a dispute over a blockbuster hepatitis C treatment.
  Reuters Health Information, January 19, 2021
• Eliminating Hepatitis by 2030: HHS Releases New Strategic Plan In an effort to counteract alarming trends in rising hepatitis infections, the HHS has developed and released its Viral Hepatitis National Strategic Plan 2021-2025.
  Medscape Medical News, January 15, 2021
• HCV Declines Level Off in HIV+ Men Who Have Sex With Men The incidence of hepatitis C virus infection among HIV-positive men who have sex with men in the Netherlands fell once direct-acting antivirals became universally available in 2015, new findings show.
  Reuters Health Information, January 08, 2021
• The Lifesaving Potential of Less-Than-Perfect Donor Kidneys Demand for healthy kidneys has long outstripped supply. But better testing and treatment are expanding the donor pool.
  Undark, December 17, 2020
• One-Year Transplant Outcomes Similar With Kidneys From HCV+, HCV- Donors Outcomes for renal transplants from hepatitis C virus (HCV)-infected donors to HCV-negative recipients are similar to those for HCV-negative patients who receive kidneys from donors without HCV, according to a one-year follow-up study.
  Reuters Health Information, December 15, 2020
• Nobel Laureates on Their Hunt for the Cure The 2020 Nobel Prize in Medicine was awarded to three scientists who discovered hepatitis C, an RNA virus that was curbed by common-sense public health measures before new antivirals could save lives.
  Medscape Medical News, December 09, 2020
• Patients Cured of HCV Still at High Liver Cancer Risk The burden of hepatocellular carcinoma (HCC) appears likely to move from patients who currently have hepatitis C virus (HCV) infection to those who have previously been cured, a new modeling study suggests.
  Reuters Health Information, November 25, 2020
• Combo DAA May Benefit Patients With Resistant HCV Genotype 3 A meta-analysis of 34 research reports found that direct-acting antiviral (DAA) combo treatment can be effective in achieving sustained virologic response in patients with HCV genotype 3.
  Medscape Medical News, November 23, 2020
• Opt-Out Policy Increased HIV/HCV Testing Bundled opt-out HIV/hepatitis C virus (HCV) testing increased the percentage of syringe service program (SSP) clients who received HIV and HCV rapid tests at enrollment into the program.
  Medscape Medical News, November 19, 2020
• ANAC 2020 HCV Care Can Learn a Thing or Two From the HIV Experience Patients with hepatitis C virus and HIV share some of the same treatment challenges, suggesting similar care models can be used for these conditions to improve rates of treatment adherence and success.
  Medscape Medical News, November 14, 2020
• COVID-19 Linked to Increased Risk for Parkinson's One of the neurologic complications of COVID-19 may be the development of Parkinson's disease, a new report suggests.
  Medscape Medical News, November 05, 2020
• Health Care Groups Dive Into Property Tax Ballot Fight They see Proposition 15 as a potential savior for chronically underfunded local health departments struggling to respond to the worst public health crisis in more than a century.
  Kaiser Health News, October 20, 2020
• Alert Trio Awarded Nobel Prize in Medicine for Discovering Hep C Virus The achievement by two Americans and a British-born scientist rapidly led to medications, blood tests, a cure, and 'hopes of eradicating hepatitis C virus from the world population.'
  Medscape Medical News, October 05, 2020
• Why Are So Few Drugs Tested for Safety in Pregnancy? Expectant mothers have long been excluded from clinical trials. Some experts say this practice needs to change.
  Undark, October 01, 2020